Association of SCN1A Polymorphisms rs3812718 and rs2298771 with Epilepsy
Genes · 2024
DOI: 10.3390/genes15091224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Martha-Spyridoula Katsarou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of…. Hauptthemen laut MEDLINE: NAV1.1 Voltage-Gated Sodium Channel, Polymorphism, Single Nucleotide, Epilepsy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Epilepsy is a brain disease with both environmental and genetic inputs. Ion channel dysfunction seems to be of great significance for abnormal neuronal behavior during epileptic seizures. Within neurons, the voltage-gated sodium channels are crucial proteins contributing to the initiation and propagation of action potentials. The voltage-gated sodium channel α subunit 1 (SCN1A) gene encodes for the α subunit of a voltage-gated ion channel. The aim of the study was to investigate the relation of two common SCN1A variants, i.e., rs3812718 and rs2298771, with distinct epileptic phenotypes in a South-Eastern European population.
Methods
DNA was extracted from 214 unrelated participants with focal onset, focal to bilateral tonic–clonic, or generalized onset epileptic seizures and genotyped using real-time PCR (LightSNiP assays) followed by melting curve analysis. Statistical analysis of the results was performed using IBM SPSS Statistics software (version 29.0 for Windows).
Results
Genotype frequency distribution analysis indicated an association for the A-allele-containing genotypes of both rs3812718 and rs2298771 polymorphisms of SCN1A with generalized onset seizures and focal to bilateral tonic–clonic seizures versus focal onset seizures.
Conclusions
Consequently, the study provides evidence that supports a potential association of the investigated SCN1A polymorphisms with distinct seizure subtype susceptibility in South-Eastern Europeans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece.
- Epilepsy Unit, First Department of Neurosurgery, Evangelismos Hospital, School of Medicine, National and Kapodistrian University of Athens, 15771 Athens, Greece.
- Department of Pharmacy, School of Health Sciences, Frederick University, 1036 Nicosia, Cyprus.
ORCID-Profile: Maria Stefanatou, Anastasia Verentzioti, Stylianos Gatzonis, Nikolaos Drakoulis
Zitieren
APA
Katsarou, M. S., Siatouni, A., Tsikrika, D., Kokkiou, E., Stefanatou, M., Verentzioti, A., Alexoudi, A., Gatzonis, S., Drakoulis, N., & Papasavva, M. (2024). Association of SCN1A Polymorphisms rs3812718 and rs2298771 with Epilepsy. Genes. https://doi.org/10.3390/genes15091224
Vancouver
Katsarou MS, Siatouni A, Tsikrika D, Kokkiou E, Stefanatou M, Verentzioti A, et al. Association of SCN1A Polymorphisms rs3812718 and rs2298771 with Epilepsy. Genes. 2024. doi:10.3390/genes15091224
BibTeX
@article{Katsarou2024,
author = {Katsarou, Martha-Spyridoula and Siatouni, Anna and Tsikrika, Danae and Kokkiou, Elena and Stefanatou, Maria and Verentzioti, Anastasia and Alexoudi, Athanasia and Gatzonis, Stylianos and Drakoulis, Nikolaos and Papasavva, Maria},
title = {Association of SCN1A Polymorphisms rs3812718 and rs2298771 with Epilepsy},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15091224}
}
EUVIMED